Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials

In this study, the authors did not find any evidence of difference in the treatment effect of apalutamide on OS across patients of different races, although interpretation remains limited by poor representation of racial minorities. Among apalutamide-treated patients, there was no association of race with OS.